Assessing the Use of Wrist-Worn Devices in Patients With Heart Failure: Feasibility Study

Related Article This is a corrected version. See correction statement in: http://cardio.jmir.org/2018/1/e10149/ Background: Exercise capacity and raised heart rate (HR) are important prognostic markers in patients with heart failure (HF). There has been significant interest in wrist-worn devices tha...

Full description

Saved in:
Bibliographic Details
Published in:JMIR cardio 2017-12, Vol.1 (2), p.e8-e8
Main Authors: Moayedi, Yasbanoo, Abdulmajeed, Raghad, Duero Posada, Juan, Foroutan, Farid, Alba, Ana Carolina, Cafazzo, Joseph, Ross, Heather Joan
Format: Article
Language:English
Subjects:
Accuracy
Confidence intervals
Electrocardiography
Enzymes
Exercise
Exercise physiology
Feasibility studies
Heart failure
Heart rate
Original Paper
Physical fitness
Wearable computers
Workloads
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Related Article This is a corrected version. See correction statement in: http://cardio.jmir.org/2018/1/e10149/ Background: Exercise capacity and raised heart rate (HR) are important prognostic markers in patients with heart failure (HF). There has been significant interest in wrist-worn devices that track activity and HR. Objective: We aimed to assess the feasibility and accuracy of HR and activity tracking of the Fitbit and Apple Watch. Methods: We conducted a two-phase study assessing the accuracy of HR by Apple Watch and Fitbit in healthy participants. In Phase 1, 10 healthy individuals wore a Fitbit, an Apple Watch, and a GE SEER Light 5-electrode Holter monitor while exercising on a cycle ergometer with a 10-watt step ramp protocol from 0-100 watts. In Phase 2, 10 patients with HF and New York Heart Association (NYHA) Class II-III symptoms wore wrist devices for 14 days to capture overall step count/exercise levels. Results: Recorded HR by both wrist-worn devices had the best agreement with Holter readings at a workload of 60-100 watts when the rate of change of HR is less dynamic. Fitbit recorded a mean 8866 steps/day for NYHA II patients versus 4845 steps/day for NYHA III patients (P=.04). In contrast, Apple Watch recorded a mean 7027 steps/day for NYHA II patients and 4187 steps/day for NYHA III patients (P=.08). Conclusions: Both wrist-based devices are best suited for static HR rate measurements. In an outpatient setting, these devices may be adequate for average HR in patients with HF. When assessing exercise capacity, the Fitbit better differentiated patients with NYHA II versus NYHA III by the total number of steps recorded. This exploratory study indicates that these wrist-worn devices show promise in prognostication of HF in the continuous monitoring of outpatients.
ISSN:2561-1011
2561-1011
DOI:10.2196/cardio.8301